US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Provident

23.16

-0.1700-0.73%

Post-market: 23.10-0.0600-0.26%17:18 EDT

Volume:1.64M

Turnover:37.94M

Market Cap:3.03B

PE:9.66

High:23.43

Open:23.35

Low:22.69

Close:23.33

52wk High:25.49

52wk Low:17.69

Shares:130.62M

Float Shares:126.13M

Volume Ratio:2.15

T/O Rate:1.30%

Dividend:0.96

Dividend Rate:4.14%

EPS(TTM):2.40

EPS(LYR):2.23

ROE:11.14%

ROA:1.25%

PB:1.04

PE(LYR):10.38

Loading ...

Overview Company News Filings

Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma

Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

GT Biopharma Reports First Quarter 2026 Financial Results

Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update

Inflation, Debt, and a Housing Standstill: Provident Bank's 2026 Consumer Survey Captures the State of American Household Finances

USA Rare Earth Reports First Quarter 2026 Financial Results

Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

Press Release: Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Press Release: BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress

George Lista, Pres/CEO Prov Protection Plus, sells 2,556 Provident Financial shares for $57,254.4

Press Release: Immatics Announces First Quarter 2026 Financial Results and Business Update

Turaco Gold Identifies Gold Mineralization at Ivory Coast Project

MT Newswires Live

TMC and Allseas Sign Commercial Agreement for the First Offshore Nodule Recovery Operation

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

Provident Financial Q1 FY26 net income rises 24.1% to $79.4 million; net interest margin widens 6 bps to 3.4%

Press Release: Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PFS/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PFS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident","latestPrice":23.16,"timestamp":1789588800000,"preClose":23.33,"halted":0,"volume":1639220,"hourTrading":{"tag":"盘后","latestPrice":23.1,"preClose":23.16,"latestTime":"17:18 EDT","volume":109043,"amount":2525435.6619140003,"timestamp":1789593533659,"change":-0.06,"changeRate":-0.002591,"amplitude":0.003022},"delay":0,"changeRate":-0.007286755250750028,"floatShares":126131374,"shares":130622384,"eps":2.396834,"marketStatus":"Post-Mkt","change":-0.17,"latestTime":"09-16 19:18:30 EDT","open":23.35,"high":23.43,"low":22.69,"amount":37944505.55566,"amplitude":0.031719,"askPrice":23.6,"askSize":10,"bidPrice":22.72,"bidSize":10,"shortable":3,"etf":0,"ttmEps":2.396834,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1042693200000,"exchange":"NYSE","adjPreClose":23.33,"dividendRate":0.041421,"postHourTrading":{"tag":"盘后","latestPrice":23.1,"preClose":23.16,"latestTime":"17:18 EDT","volume":109043,"amount":2525435.6619140003,"timestamp":1789593533659,"change":-0.06,"changeRate":-0.002591,"amplitude":0.003022},"volumeRatio":2.151546,"impliedVol":0.1734,"impliedVolPercentile":0.1474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","floatShares":126131374,"roa":"1.25%","roe":"11.14%","lyrEps":2.231753,"volumeRatio":2.151546,"shares":130622384,"dividePrice":0.9593,"high":23.43,"amplitude":0.031719,"preClose":23.33,"low":22.69,"week52Low":17.69,"pbRate":"1.04","psRate":"3.38","week52High":25.49,"institutionHeld":0.753,"latestPrice":23.16,"eps":2.396834,"divideRate":0.041421,"volume":1639220,"delay":0,"ttmEps":2.396834,"open":23.35,"prevYearClose":19.75,"prevWeekClose":23.3,"prevMonthClose":23.4,"prevQuarterClose":23.64,"fiveDayClose":23.11,"twentyDayClose":24.46,"sixtyDayClose":23.01,"dividendPayoutRate":0.4301551291742411,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.047123599311239044},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFS\",params:#limit:5,,,undefined,":[{"date":"2026-08-14","symbol":"PFS","amount":0.24,"announcedDate":"2026-07-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-28","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-28"},{"market":"US","date":"2026-07-29","symbol":"PFS","fiscalQuarterEnding":"2026/06","expectedEps":0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785297600000,"reportTimeType":"post","actualEps":0.6},{"date":"2026-05-15","symbol":"PFS","amount":0.24,"announcedDate":"2026-04-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-15","defaultRemindTime":1778851800000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-15","currency":"USD","dateTimestamp":1778817600000,"payDate":"2026-05-29"},{"date":"2026-04-29","symbol":"PFS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":0.55,"defaultRemindTime":1777492800000,"name":null,"time":"Post-Mkt","dateTimestamp":1777435200000,"actualEps":null},{"date":"2026-02-13","symbol":"PFS","amount":0.24,"announcedDate":"2026-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-13","defaultRemindTime":1770993000000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-13","currency":"USD","dateTimestamp":1770958800000,"payDate":"2026-02-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFS\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-10","recordDate":"2016-11-15","paymentDate":"2016-11-30","value":0.18,"currency":"USD"},{"executeDate":"2017-02-13","recordDate":"2017-02-15","paymentDate":"2017-02-28","value":0.19,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-05-31","value":0.19,"currency":"USD"},{"executeDate":"2017-08-11","recordDate":"2017-08-15","paymentDate":"2017-08-31","value":0.2,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":"2017-11-15","paymentDate":"2017-11-30","value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.5,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1780977600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFS","date":"2026-09-15","current":9.760793,"percent":0.315663,"low":6.410614,"twenty":8.983715,"median":10.282823,"eighty":14.885242,"high":33.979783,"avg":12.650812,"sd":6.39957,"marketCap":3044063904},"quantilePoints":[{"date":"2021-09-17","current":10.542557,"twenty":12.463634,"median":15.915973,"eighty":18.884491,"marketCap":1697952653},{"date":"2021-09-24","current":10.841334,"twenty":12.367008,"median":15.852207,"eighty":18.884491,"marketCap":1746072768},{"date":"2021-10-01","current":11.315583,"twenty":12.317066,"median":15.827979,"eighty":18.884491,"marketCap":1822453904},{"date":"2021-10-08","current":11.718695,"twenty":12.271397,"median":15.788905,"eighty":18.884491,"marketCap":1887377870},{"date":"2021-10-15","current":11.713953,"twenty":12.250326,"median":15.716295,"eighty":18.884491,"marketCap":1886614059},{"date":"2021-10-22","current":11.808802,"twenty":12.188782,"median":15.680935,"eighty":18.884491,"marketCap":1901890286},{"date":"2021-10-29","current":11.169949,"twenty":12.144658,"median":15.649322,"eighty":18.884491,"marketCap":1912127768},{"date":"2021-11-05","current":11.584988,"twenty":12.022084,"median":15.636232,"eighty":18.884491,"marketCap":1983176134},{"date":"2021-11-12","current":11.413559,"twenty":11.87183,"median":15.555472,"eighty":18.877325,"marketCap":1953830070},{"date":"2021-11-19","current":11.06619,"twenty":11.803248,"median":15.475641,"eighty":18.822017,"marketCap":1894365677},{"date":"2021-11-26","current":10.935362,"twenty":11.752841,"median":15.361209,"eighty":18.799671,"marketCap":1871969996},{"date":"2021-12-03","current":10.660174,"twenty":11.700674,"median":15.25837,"eighty":18.766081,"marketCap":1824861840},{"date":"2021-12-10","current":10.64664,"twenty":11.597269,"median":15.189807,"eighty":18.713257,"marketCap":1822545046},{"date":"2021-12-17","current":10.745888,"twenty":11.515514,"median":15.166494,"eighty":18.654746,"marketCap":1839534872},{"date":"2021-12-23","current":10.957919,"twenty":11.442431,"median":15.126556,"eighty":18.639247,"marketCap":1875831320},{"date":"2021-12-31","current":10.92634,"twenty":11.368446,"median":15.085589,"eighty":18.621596,"marketCap":1870425466},{"date":"2022-01-07","current":11.738372,"twenty":11.326022,"median":15.058778,"eighty":18.579091,"marketCap":2009433139},{"date":"2022-01-14","current":11.729349,"twenty":11.326022,"median":15.040904,"eighty":18.531427,"marketCap":2007888610},{"date":"2022-01-21","current":10.863182,"twenty":11.299875,"median":15.028989,"eighty":18.489553,"marketCap":1859613758},{"date":"2022-01-28","current":11.023748,"twenty":11.261979,"median":15.001772,"eighty":18.453467,"marketCap":1851118845},{"date":"2022-02-04","current":11.088134,"twenty":11.181448,"median":14.930112,"eighty":18.423167,"marketCap":1861930553},{"date":"2022-02-11","current":10.92717,"twenty":11.115728,"median":14.912327,"eighty":18.41438,"marketCap":1834901283},{"date":"2022-02-18","current":10.92717,"twenty":11.065654,"median":14.87528,"eighty":18.386528,"marketCap":1834901283},{"date":"2022-02-25","current":10.732094,"twenty":11.023748,"median":14.820597,"eighty":18.371521,"marketCap":1802143926},{"date":"2022-03-04","current":10.629654,"twenty":11.007105,"median":14.772796,"eighty":18.349914,"marketCap":1784942161},{"date":"2022-03-11","current":10.652348,"twenty":10.957288,"median":14.734826,"eighty":18.315942,"marketCap":1788752883},{"date":"2022-03-18","current":10.806664,"twenty":10.92634,"median":14.709739,"eighty":18.308123,"marketCap":1814665792},{"date":"2022-03-25","current":10.720428,"twenty":10.866543,"median":14.669048,"eighty":18.291682,"marketCap":1800185049},{"date":"2022-04-01","current":10.629654,"twenty":10.847714,"median":14.635382,"eighty":18.253335,"marketCap":1784942161},{"date":"2022-04-08","current":10.053238,"twenty":10.819838,"median":14.583758,"eighty":18.229989,"marketCap":1688149823},{"date":"2022-04-14","current":10.071393,"twenty":10.805336,"median":14.512906,"eighty":18.210171,"marketCap":1691198401},{"date":"2022-04-22","current":10.171245,"twenty":10.764,"median":14.497563,"eighty":18.192392,"marketCap":1707965577},{"date":"2022-04-29","current":10.150722,"twenty":10.733654,"median":14.451873,"eighty":18.177577,"marketCap":1657856535},{"date":"2022-05-06","current":10.297502,"twenty":10.713769,"median":14.383195,"eighty":18.14275,"marketCap":1681829155},{"date":"2022-05-13","current":9.954658,"twenty":10.67461,"median":14.304676,"eighty":18.117189,"marketCap":1625834598},{"date":"2022-05-20","current":10.078233,"twenty":10.650249,"median":14.249341,"eighty":18.096905,"marketCap":1646017372},{"date":"2022-05-27","current":10.572534,"twenty":10.629654,"median":14.193648,"eighty":18.064002,"marketCap":1726748469},{"date":"2022-06-03","current":10.412344,"twenty":10.620376,"median":14.117725,"eighty":18.057139,"marketCap":1700585614},{"date":"2022-06-10","current":10.000427,"twenty":10.605236,"median":13.994542,"eighty":18.016495,"marketCap":1633309699},{"date":"2022-06-17","current":9.92262,"twenty":10.570637,"median":13.872371,"eighty":17.998745,"marketCap":1620602026},{"date":"2022-06-24","current":10.165194,"twenty":10.552314,"median":13.685465,"eighty":17.991294,"marketCap":1660220065},{"date":"2022-07-01","current":10.513034,"twenty":10.530137,"median":13.611721,"eighty":17.968495,"marketCap":1717030837},{"date":"2022-07-08","current":10.31623,"twenty":10.524934,"median":13.456373,"eighty":17.95339,"marketCap":1684887900},{"date":"2022-07-15","current":10.288769,"twenty":10.512341,"median":13.392091,"eighty":17.910649,"marketCap":1680402839},{"date":"2022-07-22","current":10.613725,"twenty":10.505887,"median":13.327225,"eighty":17.849237,"marketCap":1733476061},{"date":"2022-07-29","current":11.467199,"twenty":10.505887,"median":13.302306,"eighty":17.813962,"marketCap":1809111112},{"date":"2022-08-05","current":11.377758,"twenty":10.505887,"median":13.239282,"eighty":17.786291,"marketCap":1795000639},{"date":"2022-08-12","current":11.739288,"twenty":10.505887,"median":13.221695,"eighty":17.762714,"marketCap":1852037025},{"date":"2022-08-19","current":11.748717,"twenty":10.505887,"median":13.209959,"eighty":17.748875,"marketCap":1853524605},{"date":"2022-08-26","current":11.296118,"twenty":10.505887,"median":13.188531,"eighty":17.733901,"marketCap":1782120768},{"date":"2022-09-02","current":10.848234,"twenty":10.505887,"median":13.150076,"eighty":17.684237,"marketCap":1711460720},{"date":"2022-09-09","current":10.928381,"twenty":10.505887,"median":13.130958,"eighty":17.66138,"marketCap":1724105150},{"date":"2022-09-16","current":11.036817,"twenty":10.505887,"median":13.113536,"eighty":17.644475,"marketCap":1741212319},{"date":"2022-09-23","current":10.980242,"twenty":10.505887,"median":13.081395,"eighty":17.623016,"marketCap":1732286840},{"date":"2022-09-30","current":9.193418,"twenty":10.478391,"median":13.065324,"eighty":17.59628,"marketCap":1450390441},{"date":"2022-10-07","current":9.075554,"twenty":10.469523,"median":13.052449,"eighty":17.561143,"marketCap":1431795692},{"date":"2022-10-14","current":9.580013,"twenty":10.437974,"median":13.034632,"eighty":17.546569,"marketCap":1511381219},{"date":"2022-10-21","current":9.716736,"twenty":10.425892,"median":13.011756,"eighty":17.514492,"marketCap":1532951128},{"date":"2022-10-28","current":10.271339,"twenty":10.389888,"median":12.992653,"eighty":17.479985,"marketCap":1683636796},{"date":"2022-11-04","current":10.266754,"twenty":10.377223,"median":12.955005,"eighty":17.444428,"marketCap":1682885173},{"date":"2022-11-11","current":10.291061,"twenty":10.357421,"median":12.934931,"eighty":17.408903,"marketCap":1686869566},{"date":"2022-11-18","current":10.064186,"twenty":10.320716,"median":12.924436,"eighty":17.359105,"marketCap":1649681083},{"date":"2022-11-25","current":10.272911,"twenty":10.310098,"median":12.883192,"eighty":17.323674,"marketCap":1683894487},{"date":"2022-12-02","current":10.204848,"twenty":10.293993,"median":12.857307,"eighty":17.216387,"marketCap":1672737942},{"date":"2022-12-09","current":9.973436,"twenty":10.282719,"median":12.842174,"eighty":17.162345,"marketCap":1634805690},{"date":"2022-12-16","current":9.360873,"twenty":10.269156,"median":12.829982,"eighty":17.036971,"marketCap":1534396787},{"date":"2022-12-23","current":9.719335,"twenty":10.253097,"median":12.811402,"eighty":16.964208,"marketCap":1593154590},{"date":"2022-12-30","current":9.69211,"twenty":10.230259,"median":12.79325,"eighty":16.866633,"marketCap":1588691972},{"date":"2023-01-06","current":9.896298,"twenty":10.216454,"median":12.770698,"eighty":16.761899,"marketCap":1622161606},{"date":"2023-01-13","current":10.150398,"twenty":10.193425,"median":12.743914,"eighty":16.690368,"marketCap":1663812707},{"date":"2023-01-20","current":10.213923,"twenty":10.187062,"median":12.725033,"eighty":16.523587,"marketCap":1674225482},{"date":"2023-01-27","current":9.790009,"twenty":10.173843,"median":12.690346,"eighty":16.324736,"marketCap":1719595430},{"date":"2023-02-03","current":10.396723,"twenty":10.16752,"median":12.677807,"eighty":16.256402,"marketCap":1826163591},{"date":"2023-02-10","current":10.238158,"twenty":10.16752,"median":12.667312,"eighty":16.23143,"marketCap":1798311961},{"date":"2023-02-17","current":10.259586,"twenty":10.15802,"median":12.637027,"eighty":16.127135,"marketCap":1802075695},{"date":"2023-02-24","current":10.011024,"twenty":10.149032,"median":12.580612,"eighty":16.062409,"marketCap":1758416384},{"date":"2023-03-03","current":9.946656,"twenty":10.12732,"median":12.54984,"eighty":16.029311,"marketCap":1747110222},{"date":"2023-03-10","current":8.806492,"twenty":10.110262,"median":12.491259,"eighty":15.99002,"marketCap":1546842669},{"date":"2023-03-17","current":8.551231,"twenty":10.087476,"median":12.467781,"eighty":15.924154,"marketCap":1502006690},{"date":"2023-03-24","current":8.308734,"twenty":10.075497,"median":12.378703,"eighty":15.861307,"marketCap":1459412470},{"date":"2023-03-31","current":8.159832,"twenty":10.060803,"median":12.352386,"eighty":15.839714,"marketCap":1433258125},{"date":"2023-04-06","current":7.704617,"twenty":10.04356,"median":12.287536,"eighty":15.796939,"marketCap":1353300555},{"date":"2023-04-14","current":7.832247,"twenty":10.027135,"median":12.261119,"eighty":15.730693,"marketCap":1375718565},{"date":"2023-04-21","current":7.74716,"twenty":10.017452,"median":12.211348,"eighty":15.694,"marketCap":1360773225},{"date":"2023-04-28","current":7.593207,"twenty":9.999766,"median":12.160062,"eighty":15.664957,"marketCap":1307717267},{"date":"2023-05-05","current":6.573548,"twenty":9.989771,"median":12.09154,"eighty":15.642667,"marketCap":1132109520},{"date":"2023-05-12","current":6.495446,"twenty":9.971621,"median":11.987273,"eighty":15.600987,"marketCap":1118658713},{"date":"2023-05-19","current":7.029498,"twenty":9.961387,"median":11.888242,"eighty":15.530275,"marketCap":1210634281},{"date":"2023-05-26","current":7.046909,"twenty":9.952827,"median":11.808802,"eighty":15.39865,"marketCap":1213632756},{"date":"2023-06-02","current":7.116551,"twenty":9.943684,"median":11.780347,"eighty":15.324881,"marketCap":1225626656},{"date":"2023-06-09","current":7.90873,"twenty":9.929925,"median":11.738372,"eighty":15.203096,"marketCap":1362057268},{"date":"2023-06-16","current":7.934846,"twenty":9.905841,"median":11.713953,"eighty":15.174007,"marketCap":1366554981},{"date":"2023-06-23","current":7.221014,"twenty":9.886325,"median":11.649929,"eighty":15.134319,"marketCap":1243617506},{"date":"2023-06-30","current":7.260188,"twenty":9.866996,"median":11.584988,"eighty":15.109317,"marketCap":1250364075},{"date":"2023-07-07","current":6.946798,"twenty":9.848756,"median":11.548897,"eighty":15.068412,"marketCap":1196391525},{"date":"2023-07-14","current":7.499583,"twenty":9.820363,"median":11.505283,"eighty":15.049841,"marketCap":1291593106},{"date":"2023-07-21","current":8.108951,"twenty":9.78572,"median":11.467199,"eighty":15.032889,"marketCap":1396539731},{"date":"2023-07-28","current":8.682159,"twenty":9.742349,"median":11.428126,"eighty":15.003286,"marketCap":1432521431},{"date":"2023-08-04","current":8.409258,"twenty":9.731294,"median":11.387173,"eighty":14.9415,"marketCap":1387493907},{"date":"2023-08-11","current":8.120111,"twenty":9.718285,"median":11.354912,"eighty":14.916422,"marketCap":1339785831},{"date":"2023-08-18","current":7.624539,"twenty":9.704927,"median":11.300777,"eighty":14.879018,"marketCap":1258018387},{"date":"2023-08-25","current":7.506329,"twenty":9.663774,"median":11.282731,"eighty":14.826043,"marketCap":1238514226},{"date":"2023-09-01","current":7.492689,"twenty":9.624389,"median":11.244446,"eighty":14.781733,"marketCap":1236263745},{"date":"2023-09-08","current":7.310828,"twenty":9.599052,"median":11.197237,"eighty":14.751943,"marketCap":1206257344},{"date":"2023-09-15","current":7.388119,"twenty":9.572255,"median":11.168825,"eighty":14.716388,"marketCap":1219010065},{"date":"2023-09-22","current":6.997117,"twenty":9.538302,"median":11.11225,"eighty":14.678775,"marketCap":1154496301},{"date":"2023-09-29","current":6.951652,"twenty":9.501581,"median":11.06619,"eighty":14.644899,"marketCap":1146994701},{"date":"2023-10-06","current":6.951652,"twenty":9.471361,"median":11.046743,"eighty":14.595078,"marketCap":1146994701},{"date":"2023-10-13","current":6.792523,"twenty":9.431033,"median":11.012054,"eighty":14.515019,"marketCap":1120739099},{"date":"2023-10-20","current":6.542463,"twenty":9.372419,"median":10.980475,"eighty":14.499896,"marketCap":1079480297},{"date":"2023-10-27","current":7.170747,"twenty":9.358917,"median":10.957919,"eighty":14.471655,"marketCap":1076479657},{"date":"2023-11-03","current":7.537213,"twenty":9.227549,"median":10.936586,"eighty":14.399708,"marketCap":1131493992},{"date":"2023-11-10","current":7.179977,"twenty":9.151165,"median":10.92634,"eighty":14.31961,"marketCap":1077865333},{"date":"2023-11-17","current":7.734589,"twenty":9.108811,"median":10.883634,"eighty":14.267749,"marketCap":1161124242},{"date":"2023-11-24","current":7.594687,"twenty":9.078197,"median":10.857,"eighty":14.214839,"marketCap":1140121995},{"date":"2023-12-01","current":7.60468,"twenty":8.976162,"median":10.840069,"eighty":14.143037,"marketCap":1141622155},{"date":"2023-12-08","current":8.214253,"twenty":8.928966,"median":10.82028,"eighty":14.03685,"marketCap":1233131947},{"date":"2023-12-15","current":9.103631,"twenty":8.896863,"median":10.805953,"eighty":13.930523,"marketCap":1366646233},{"date":"2023-12-22","current":9.083645,"twenty":8.896863,"median":10.78687,"eighty":13.759594,"marketCap":1363645912},{"date":"2023-12-29","current":9.223547,"twenty":8.892939,"median":10.761277,"eighty":13.668342,"marketCap":1384648159},{"date":"2024-01-05","current":8.743883,"twenty":8.862382,"median":10.745888,"eighty":13.56351,"marketCap":1312640455},{"date":"2024-01-12","current":8.583995,"twenty":8.806492,"median":10.720428,"eighty":13.408162,"marketCap":1288637886},{"date":"2024-01-19","current":8.309187,"twenty":8.772881,"median":10.697142,"eighty":13.342249,"marketCap":1247383472},{"date":"2024-01-26","current":8.828824,"twenty":8.752732,"median":10.656886,"eighty":13.316627,"marketCap":1325391819},{"date":"2024-02-02","current":9.490046,"twenty":8.752732,"median":10.64215,"eighty":13.30073,"marketCap":1218502920},{"date":"2024-02-09","current":8.830529,"twenty":8.752732,"median":10.629654,"eighty":13.236743,"marketCap":1133822213},{"date":"2024-02-16","current":9.326626,"twenty":8.752732,"median":10.620577,"eighty":13.221244,"marketCap":1197520090},{"date":"2024-02-23","current":8.865547,"twenty":8.752732,"median":10.61055,"eighty":13.209959,"marketCap":1138318534},{"date":"2024-03-01","current":8.801346,"twenty":8.74965,"median":10.589265,"eighty":13.19135,"marketCap":1130075279},{"date":"2024-03-08","current":8.986315,"twenty":8.743883,"median":10.567288,"eighty":13.154274,"marketCap":1153824926},{"date":"2024-03-15","current":8.329352,"twenty":8.723902,"median":10.538449,"eighty":13.128485,"marketCap":1069472190},{"date":"2024-03-22","current":8.96157,"twenty":8.698898,"median":10.5269,"eighty":13.112465,"marketCap":1150647615},{"date":"2024-03-28","current":8.466976,"twenty":8.693607,"median":10.517516,"eighty":13.098537,"marketCap":1087142753},{"date":"2024-04-05","current":8.466976,"twenty":8.653336,"median":10.488954,"eighty":13.065324,"marketCap":1087142753},{"date":"2024-04-12","current":7.990046,"twenty":8.61897,"median":10.476162,"eighty":13.052449,"marketCap":1025905922},{"date":"2024-04-19","current":8.671317,"twenty":8.578848,"median":10.466677,"eighty":13.034632,"marketCap":1040072426},{"date":"2024-04-26","current":9.585747,"twenty":8.579877,"median":10.437517,"eighty":13.020302,"marketCap":1149752791},{"date":"2024-05-03","current":9.605463,"twenty":8.579877,"median":10.431596,"eighty":12.999364,"marketCap":1152117669},{"date":"2024-05-10","current":10.091416,"twenty":8.579877,"median":10.40199,"eighty":12.962642,"marketCap":1210404831},{"date":"2024-05-17","current":10.167149,"twenty":8.579877,"median":10.387579,"eighty":12.944965,"marketCap":1219488545},{"date":"2024-05-24","current":9.554974,"twenty":8.579877,"median":10.368229,"eighty":12.926046,"marketCap":1146061860},{"date":"2024-05-31","current":15.595237,"twenty":8.579877,"median":10.368229,"eighty":12.928956,"marketCap":1870555147},{"date":"2024-06-07","current":14.804645,"twenty":8.579877,"median":10.368229,"eighty":12.944965,"marketCap":1775728393},{"date":"2024-06-14","current":14.479745,"twenty":8.579877,"median":10.368229,"eighty":12.974084,"marketCap":1736758494},{"date":"2024-06-21","current":14.609705,"twenty":8.578848,"median":10.365511,"eighty":13.001042,"marketCap":1752346453},{"date":"2024-06-28","current":15.541087,"twenty":8.578848,"median":10.365511,"eighty":13.028149,"marketCap":1864060164},{"date":"2024-07-05","current":15.400297,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":1847173207},{"date":"2024-07-12","current":17.403852,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":2087487584},{"date":"2024-07-19","current":19.212466,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2304420021},{"date":"2024-07-26","current":32.346496,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2473083727},{"date":"2024-08-02","current":29.436843,"twenty":8.578848,"median":10.365511,"eighty":13.071794,"marketCap":2250623276},{"date":"2024-08-09","current":28.842709,"twenty":8.578848,"median":10.365511,"eighty":13.113823,"marketCap":2205198173},{"date":"2024-08-16","current":30.822445,"twenty":8.578848,"median":10.365511,"eighty":13.134508,"marketCap":2356560887},{"date":"2024-08-23","current":32.631515,"twenty":8.578848,"median":10.365511,"eighty":13.176313,"marketCap":2494875092},{"date":"2024-08-30","current":32.546181,"twenty":8.578848,"median":10.365511,"eighty":13.215944,"marketCap":2488350837},{"date":"2024-09-06","current":31.197913,"twenty":8.578848,"median":10.365511,"eighty":13.228055,"marketCap":2385267609},{"date":"2024-09-13","current":31.300313,"twenty":8.578848,"median":10.365511,"eighty":13.30073,"marketCap":2393096715},{"date":"2024-09-20","current":32.187781,"twenty":8.578848,"median":10.365511,"eighty":13.316627,"marketCap":2460948967},{"date":"2024-09-27","current":31.283246,"twenty":8.578848,"median":10.365511,"eighty":13.405115,"marketCap":2391791864},{"date":"2024-10-04","current":30.429912,"twenty":8.578848,"median":10.365511,"eighty":13.64376,"marketCap":2326549315},{"date":"2024-10-11","current":32.136581,"twenty":8.578848,"median":10.365511,"eighty":13.888037,"marketCap":2457034414},{"date":"2024-10-18","current":33.314182,"twenty":8.578848,"median":10.365511,"eighty":14.144229,"marketCap":2547069132},{"date":"2024-10-25","current":31.88058,"twenty":8.578848,"median":10.365511,"eighty":14.323115,"marketCap":2437461649},{"date":"2024-11-01","current":26.079311,"twenty":8.578848,"median":10.365511,"eighty":14.468915,"marketCap":2459644116},{"date":"2024-11-08","current":29.303632,"twenty":8.578848,"median":10.365511,"eighty":14.501405,"marketCap":2763742765},{"date":"2024-11-15","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.577215,"marketCap":2792450197},{"date":"2024-11-22","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.642195,"marketCap":2792450197},{"date":"2024-11-29","current":29.220619,"twenty":8.578848,"median":10.365511,"eighty":14.720538,"marketCap":2755913466},{"date":"2024-12-06","current":28.72254,"twenty":8.578848,"median":10.365511,"eighty":14.772155,"marketCap":2708937668},{"date":"2024-12-13","current":28.16912,"twenty":8.578848,"median":10.365511,"eighty":14.811522,"marketCap":2656742337},{"date":"2024-12-20","current":26.370502,"twenty":8.578848,"median":10.365511,"eighty":14.879507,"marketCap":2487107512},{"date":"2024-12-27","current":26.107627,"twenty":8.578848,"median":10.365511,"eighty":14.930682,"marketCap":2462314730},{"date":"2025-01-03","current":26.19064,"twenty":8.578848,"median":10.365511,"eighty":15.008136,"marketCap":2470144030},{"date":"2025-01-10","current":24.945443,"twenty":8.578722,"median":10.36461,"eighty":15.045075,"marketCap":2352704535},{"date":"2025-01-17","current":26.730225,"twenty":8.578722,"median":10.36461,"eighty":15.087294,"marketCap":2521034477},{"date":"2025-01-24","current":26.232147,"twenty":8.578722,"median":10.36461,"eighty":15.170193,"marketCap":2474058679},{"date":"2025-01-31","current":20.975271,"twenty":8.578722,"median":10.36461,"eighty":15.27162,"marketCap":2423168232},{"date":"2025-02-07","current":21.686872,"twenty":8.578722,"median":10.36461,"eighty":15.43113,"marketCap":2505375878},{"date":"2025-02-14","current":21.065633,"twenty":8.578722,"median":10.36461,"eighty":15.506431,"marketCap":2433607298},{"date":"2025-02-21","current":20.489576,"twenty":8.578722,"median":10.36461,"eighty":15.601522,"marketCap":2367058251},{"date":"2025-02-28","current":20.614008,"twenty":8.578722,"median":10.36461,"eighty":15.733365,"marketCap":2381433247},{"date":"2025-03-07","current":19.427996,"twenty":8.578596,"median":10.36371,"eighty":15.909803,"marketCap":2244419279},{"date":"2025-03-14","current":19.373214,"twenty":8.58723,"median":10.384564,"eighty":16.110435,"marketCap":2238090520},{"date":"2025-03-21","current":19.113398,"twenty":8.626133,"median":10.390798,"eighty":16.250162,"marketCap":2208075312},{"date":"2025-03-28","current":19.282843,"twenty":8.679674,"median":10.422436,"eighty":16.324736,"marketCap":2227650448},{"date":"2025-04-04","current":17.498022,"twenty":8.697705,"median":10.433885,"eighty":16.538637,"marketCap":2021459018},{"date":"2025-04-11","current":16.594315,"twenty":8.729831,"median":10.450581,"eighty":16.720339,"marketCap":1917058294},{"date":"2025-04-17","current":17.498022,"twenty":8.74788,"median":10.472646,"eighty":16.838352,"marketCap":2021459018},{"date":"2025-04-25","current":14.654875,"twenty":8.784492,"median":10.48224,"eighty":16.926427,"marketCap":2161169063},{"date":"2025-05-02","current":15.142189,"twenty":8.798752,"median":10.513034,"eighty":16.926427,"marketCap":2233033814},{"date":"2025-05-09","current":15.159534,"twenty":8.804878,"median":10.526765,"eighty":16.926427,"marketCap":2235591607},{"date":"2025-05-16","current":15.505075,"twenty":8.82909,"median":10.533858,"eighty":16.926427,"marketCap":2286548985},{"date":"2025-05-23","current":14.787412,"twenty":8.855843,"median":10.556785,"eighty":16.926427,"marketCap":2180714431},{"date":"2025-05-30","current":14.884872,"twenty":8.8606,"median":10.572534,"eighty":16.926427,"marketCap":2195087025},{"date":"2025-06-06","current":14.619071,"twenty":8.875633,"median":10.60779,"eighty":16.926427,"marketCap":2155889043},{"date":"2025-06-13","current":15.000053,"twenty":8.887975,"median":10.619572,"eighty":16.926427,"marketCap":2212072818},{"date":"2025-06-20","current":14.30011,"twenty":8.911603,"median":10.626285,"eighty":16.928687,"marketCap":2108851463},{"date":"2025-06-27","current":15.850617,"twenty":8.946056,"median":10.641658,"eighty":16.928687,"marketCap":2337506362},{"date":"2025-07-03","current":16.710041,"twenty":8.946056,"median":10.65175,"eighty":16.928687,"marketCap":2464246506},{"date":"2025-07-11","current":16.648021,"twenty":8.954399,"median":10.683931,"eighty":16.928687,"marketCap":2455100310},{"date":"2025-07-18","current":16.4974,"twenty":8.954399,"median":10.718159,"eighty":16.928687,"marketCap":2432888120},{"date":"2025-07-25","current":10.379214,"twenty":8.954399,"median":10.725223,"eighty":16.928687,"marketCap":2396954859},{"date":"2025-08-01","current":10.305683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2379973707},{"date":"2025-08-08","current":10.124683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2338173949},{"date":"2025-08-15","current":10.899581,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2517127428},{"date":"2025-08-22","current":10.633738,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2455734076},{"date":"2025-08-29","current":11.255924,"twenty":8.954399,"median":10.756738,"eighty":16.928687,"marketCap":2599420644},{"date":"2025-09-05","current":11.380362,"twenty":8.954068,"median":10.786944,"eighty":16.930946,"marketCap":2628157958},{"date":"2025-09-12","current":11.312487,"twenty":8.954399,"median":10.806309,"eighty":16.928687,"marketCap":2612483060},{"date":"2025-09-19","current":11.493487,"twenty":8.954399,"median":10.823106,"eighty":16.928687,"marketCap":2654282788},{"date":"2025-09-26","current":11.0523,"twenty":8.984755,"median":10.848771,"eighty":16.928687,"marketCap":2552395949},{"date":"2025-10-03","current":11.018362,"twenty":8.984755,"median":10.865282,"eighty":16.928687,"marketCap":2544558500},{"date":"2025-10-10","current":10.876956,"twenty":8.984755,"median":10.902195,"eighty":16.928687,"marketCap":2511902462},{"date":"2025-10-17","current":10.113363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2335559855},{"date":"2025-10-24","current":10.475363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2419159313},{"date":"2025-10-31","current":9.425046,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2415196286},{"date":"2025-11-07","current":9.328196,"twenty":8.984755,"median":10.888266,"eighty":16.928687,"marketCap":2390378153},{"date":"2025-11-14","current":9.557624,"twenty":8.984755,"median":10.857,"eighty":16.928687,"marketCap":2449169700},{"date":"2025-11-21","current":9.205903,"twenty":8.984755,"median":10.840069,"eighty":16.928687,"marketCap":2359040255},{"date":"2025-11-28","current":9.812493,"twenty":8.984755,"median":10.820894,"eighty":16.928687,"marketCap":2514480892},{"date":"2025-12-05","current":10.210091,"twenty":8.984755,"median":10.806309,"eighty":16.928687,"marketCap":2616366351},{"date":"2025-12-12","current":10.628077,"twenty":8.984755,"median":10.780942,"eighty":16.928687,"marketCap":2723476706},{"date":"2025-12-19","current":10.801389,"twenty":8.984755,"median":10.756738,"eighty":16.928687,"marketCap":2767888316},{"date":"2025-12-26","current":10.444571,"twenty":8.984755,"median":10.741206,"eighty":16.928687,"marketCap":2676452648},{"date":"2026-01-02","current":10.067363,"twenty":8.984755,"median":10.729963,"eighty":16.928687,"marketCap":2579792084},{"date":"2026-01-09","current":10.3885,"twenty":8.984755,"median":10.718159,"eighty":16.685233,"marketCap":2662084185},{"date":"2026-01-16","current":10.342623,"twenty":8.984755,"median":10.6903,"eighty":16.559093,"marketCap":2650328171},{"date":"2026-01-23","current":10.862558,"twenty":8.984755,"median":10.681432,"eighty":16.43782,"marketCap":2783563003},{"date":"2026-01-30","current":9.968317,"twenty":8.984755,"median":10.656886,"eighty":16.315692,"marketCap":2902375266},{"date":"2026-02-06","current":10.569467,"twenty":8.984755,"median":10.64505,"eighty":16.315692,"marketCap":3077405998},{"date":"2026-02-13","current":10.309268,"twenty":8.984755,"median":10.637462,"eighty":16.315692,"marketCap":3001646428},{"date":"2026-02-20","current":10.295809,"twenty":8.984755,"median":10.627766,"eighty":16.315692,"marketCap":2997727829},{"date":"2026-02-27","current":9.936914,"twenty":8.984755,"median":10.621728,"eighty":16.286003,"marketCap":2893231870},{"date":"2026-03-06","current":9.538728,"twenty":8.984755,"median":10.611113,"eighty":16.080978,"marketCap":2777296077},{"date":"2026-03-13","current":9.157179,"twenty":8.984755,"median":10.607786,"eighty":15.806317,"marketCap":2666204234},{"date":"2026-03-20","current":9.098824,"twenty":8.984755,"median":10.569303,"eighty":15.687592,"marketCap":2649213717},{"date":"2026-03-27","current":9.390597,"twenty":8.984755,"median":10.55464,"eighty":15.521024,"marketCap":2734166303},{"date":"2026-04-02","current":9.552195,"twenty":8.984755,"median":10.541989,"eighty":15.439285,"marketCap":2781216966},{"date":"2026-04-10","current":10.081875,"twenty":8.984755,"median":10.531633,"eighty":15.221375,"marketCap":2935438583},{"date":"2026-04-17","current":9.953896,"twenty":8.984755,"median":10.520516,"eighty":15.138615,"marketCap":2898176332},{"date":"2026-04-24","current":10.182155,"twenty":8.984755,"median":10.504534,"eighty":15.076332,"marketCap":2964636311},{"date":"2026-05-01","current":9.641246,"twenty":8.984755,"median":10.487837,"eighty":15.049841,"marketCap":2955514353},{"date":"2026-05-08","current":9.556088,"twenty":8.984755,"median":10.476162,"eighty":15.047458,"marketCap":2929409174},{"date":"2026-05-15","current":9.360681,"twenty":8.984755,"median":10.469048,"eighty":15.035542,"marketCap":2869507387},{"date":"2026-05-22","current":9.479709,"twenty":8.984755,"median":10.445826,"eighty":15.005753,"marketCap":2905995220},{"date":"2026-05-29","current":9.420195,"twenty":8.984235,"median":10.435776,"eighty":14.971701,"marketCap":2887751303},{"date":"2026-06-05","current":9.496713,"twenty":8.984755,"median":10.43348,"eighty":14.92465,"marketCap":2911207767},{"date":"2026-06-12","current":9.883553,"twenty":8.984755,"median":10.413427,"eighty":14.885242,"marketCap":3029793222},{"date":"2026-06-18","current":9.611489,"twenty":8.984755,"median":10.390605,"eighty":14.885242,"marketCap":2946392463},{"date":"2026-06-26","current":10.040839,"twenty":8.984235,"median":10.384564,"eighty":14.885242,"marketCap":3078009286},{"date":"2026-07-02","current":10.189624,"twenty":8.984235,"median":10.371089,"eighty":14.885242,"marketCap":3123619077},{"date":"2026-07-10","current":9.934565,"twenty":8.984235,"median":10.357421,"eighty":14.885242,"marketCap":3045430865},{"date":"2026-07-17","current":10.436182,"twenty":8.984235,"median":10.339114,"eighty":14.885242,"marketCap":3199201015},{"date":"2026-07-24","current":10.100353,"twenty":8.984235,"median":10.322233,"eighty":14.885242,"marketCap":3096253203},{"date":"2026-07-31","current":10.368248,"twenty":8.983715,"median":10.318289,"eighty":14.885242,"marketCap":3242317047},{"date":"2026-08-07","current":10.322371,"twenty":8.983715,"median":10.316612,"eighty":14.885242,"marketCap":3227970512},{"date":"2026-08-14","current":10.430773,"twenty":8.983715,"median":10.312093,"eighty":14.885242,"marketCap":3261869676},{"date":"2026-08-21","current":9.880249,"twenty":8.983715,"median":10.305232,"eighty":14.885242,"marketCap":3089711820},{"date":"2026-08-28","current":9.82603,"twenty":8.983715,"median":10.299108,"eighty":14.885242,"marketCap":3072756880},{"date":"2026-09-04","current":9.82603,"twenty":8.983715,"median":10.293769,"eighty":14.885242,"marketCap":3072756880},{"date":"2026-09-11","current":9.725935,"twenty":8.983715,"median":10.287647,"eighty":14.885242,"marketCap":3041455451},{"date":"2026-09-15","current":9.734276,"twenty":8.983715,"median":10.282823,"eighty":14.885242,"marketCap":3044063904}],"updateTime":1789577913862},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFS\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635059365","title":"Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2635059365","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635059365?lang=en_us&edition=fundamental","pubTime":"2026-05-16 08:19","pubTimestamp":1778890740,"startTime":"0","endTime":"0","summary":"The trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS) A numeric improvement of 5.1 months in median PFS was observed for the high-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/16/3296192/0/en/Regeneron-Provides-Update-on-Phase-3-Trial-of-Fianlimab-LAG-3-Inhibitor-Combination-in-First-Line-Unresectable-or-Metastatic-Melanoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","REGN","BK4195","BK4585","PFS","LU0823434583.USD","LU0320765992.SGD","LU2468319806.SGD","BK4211","LU2106854487.HKD","LU1974910355.USD","LU0882574055.USD","LU0114720955.EUR","LU2023250504.SGD","LU0058720904.USD","LU0109394709.USD","LU2362541513.USD","BK4588","LU0823434740.USD","LU2362540622.SGD","LU1917777945.USD","BK4139","LU0823416689.USD","LU2089984988.USD","LU0053666078.USD","LU0889565916.HKD","LU2362541273.HKD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635054881","title":"Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2635054881","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635054881?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:13","pubTimestamp":1778865180,"startTime":"0","endTime":"0","summary":"Celcuity expands VIKTORIA-2 to endocrine-sensitive breast cancer patients and advances injectable gedatolisib formulation.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/05/15/doctor--patient--breast-cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/05/15/doctor--patient--breast-cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/05/52608128/celcuitys-cancer-drug-expansion-could-ignite-massive-new-market-opportunity-analyst","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/05/52608128/celcuitys-cancer-drug-expansion-could-ignite-massive-new-market-opportunity-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4195","BK4211","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084932","title":"GT Biopharma Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084932","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635084932?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:00","pubTimestamp":1778846400,"startTime":"0","endTime":"0","summary":"Phase 1 trial evaluating GTB-3650 TriKE remains ongoing, with additional updates anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE in multiple solid tumor types known to express B7","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295801/0/en/GT-Biopharma-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","LU2413666426.HKD","BK4585","BK4195","BK4211","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","LU2413666699.HKD","BK4533","BK4567","IE00BFXG0V08.USD","BK4588","MTD","BK4119","LU1721428933.USD","PFS","BK4121","GT","LU2211817866.USD","GTBP","BK4139","LU1093756168.USD","LU1093756325.SGD","LU0347712357.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772538","title":"Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772538?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:15","pubTimestamp":1778789700,"startTime":"0","endTime":"0","summary":"Announced Cincinnati Children's Applied Gene and Cell Therapy Center  as Lead Manufacturing Partner. Appointed Andrew Fang, Ph.D., as Head of Business Development. BRISBANE, Calif., May 14, 2026  -- Tempest Therapeutics, Inc.  , a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today reported financial results for the quarter ended March 31, 2026, and provided a corporate update.\"We made strong progress in the first quarter as we continued to execute across our lead program TPST-2003,\" said Matt Angel, Ph.D., President and Chief Executive Officer of Tempest. \"We advanced key activities supporting the planned initiation of our U.S. registrational study of TPST-2003 in patients with rrMM, including announcing our lead manufacturing partner AGCTC and taking delivery of the TPST-2003 lentiviral vector, a critical component in the manufacturing of TPST-2003. At the same time, we strengthened our ability to unlock ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","CR","PFS","CRS","TPST","IE00B66KJ199.SGD","BK4139","BK4211","BK4022","LU0963586101.USD","IE0031619046.USD","BK4187","EMD","BK4006","IE00B7SZL793.SGD","BK4230","CAR","BK4195","IE00B19Z4B17.USD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725578","title":"Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725578","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725578?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:10","pubTimestamp":1778789400,"startTime":"0","endTime":"0","summary":"Completed successful End-of-Phase 2 meeting with the FDA and selected onvansertib dose and chemotherapy regimen for planned Phase 3 trial Company to provide detailed data update from Phase 2 CRDF-004 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295384/0/en/Cardiff-Oncology-Reports-First-Quarter-2026-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4211","CEO","PFS","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635127097","title":"Inflation, Debt, and a Housing Standstill: Provident Bank's 2026 Consumer Survey Captures the State of American Household Finances","url":"https://stock-news.laohu8.com/highlight/detail?id=2635127097","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635127097?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"New data shows how inflation, rising costs, and elevated interest rates are reshaping household finances in 2026ISELIN, N.J., May  14, 2026  (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-ba","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294848/0/en/Inflation-Debt-and-a-Housing-Standstill-Provident-Bank-s-2026-Consumer-Survey-Captures-the-State-of-American-Household-Finances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","IE00BGHQF748.EUR","LU1883839398.USD","BK4195","BK4588","AFG","BK4107","BK4585","IE00B3QW5Z07.USD","LU0061475181.USD","LU1894683348.USD","LU1894683264.USD","PFS","IE00B64PRP62.GBP","BK4135","STT","BK4117","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635755912","title":"USA Rare Earth Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635755912","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635755912?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:30","pubTimestamp":1778704200,"startTime":"0","endTime":"0","summary":"STILLWATER, Okla., May  13, 2026  (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), an emerging global leader in rare earths, today announced its financial and operational results","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294467/0/en/USA-Rare-Earth-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU1791807156.HKD","BK4195","LU2360107671.USD","BK4588","BK4585","DFS","LU1861220207.SGD","PFS","REMX","BK4168","TMRC","LCM","BK4211","LU0106831901.USD","LU1861217088.USD","BK4166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635975806","title":"Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635975806","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635975806?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:02","pubTimestamp":1778702520,"startTime":"0","endTime":"0","summary":"Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, MRD-Guided Consolidation Therapy in 1L Large B-cell Ly","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294405/0/en/Allogene-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","LU2065731478.USD","LENZ","CAR","LU0963586101.USD","BK4022","IE00B7SZL793.SGD","BK4007","BK4230","IE00B66KJ199.SGD","CRS","BK4139","BK4539","PFS","IE0031619046.USD","BK4006","BK4187","IE00B19Z4B17.USD","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786966","title":"PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786966?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"Investor Webcast Scheduled for 8:00 am ET PRINCETON, N.J., May  13, 2026  (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293836/37149/en/PDS-Biotech-Reports-First-Quarter-2026-Financial-Results-and-Provides-Clinical-Programs-and-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","ADC","BK4585","XBI","BK4231","BK4195","BK4588","ORR","BK4211","PFS","BK4092","PDS","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635792252","title":"Press Release: Innate Pharma Reports First Quarter 2026 Business Update and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635792252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635792252?lang=en_us&edition=fundamental","pubTime":"2026-05-13 13:00","pubTimestamp":1778648400,"startTime":"0","endTime":"0","summary":"lymphoma  remains planned for initiation in H2 2026, subject to. activity with favorable safety profile to date; the maximum tolerated. dose has been reached and enrollment in the Phase 1 dose escalation and. --  PACIFIC-9 Phase 3 trial, which includes monalizumab and is led by. AstraZeneca, continues to advance toward a planned H2 2026 data readout. Trials Plenary Session at AACR 2026, supporting continued investigation. \"We have continued to make solid progress across our priority clinical assets during the first quarter. We are approaching completion of enrollment in the Phase 1 dose escalation and backfill cohorts for IPH4502. In parallel, we have advanced the negotiations for non-dilutive financing options to allow initiation of the lacutamab confirmatory Phase 3 TELLOMAK-3 trial in CTCL. Finally, the Phase 3 PACIFIC-9 trial with AstraZeneca is planned for data readout in the second half of 2026. Separately, we were pleased to see encouraging results from the MATISSE Phase 2 trial","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPHA","BK4195","PFS","IPHYF","BK4022","BK4139","BK4211","BK4213","BK4232","R","CRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223869","title":"Press Release: BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223869?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:03","pubTimestamp":1778619780,"startTime":"0","endTime":"0","summary":"-- Announced encouraging preliminary safety and efficacy data across all. -- Announced publication in Cancer Discovery highlighting preclinical data. demonstrating BBO-11818 is a potent and selective pan-KRAS inhibitor. -- Clinical readouts expected in the second half of 2026 across all three. -- Cash runway expected to fund operations into 2028. SOUTH SAN FRANCISCO, Calif., May 12, 2026  -- BridgeBio Oncology Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today reported financial results for the first quarter ended March 31, 2026, and provided a business update, including highlights of pipeline progress.BBOT's portfolio of late-stage RAS-pathway inhibitors is designed to enable direct dual inhibition of KRAS in both its ON and OFF states, pan-KRAS coverage across major KRAS mutations, and disruption of RAS-driven PI3K<ALPHA> activation. Together, these assets uniquely position BBOT to achieve safe, concurrent, high-level suppressi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2298322129.HKD","LU0456854461.SGD","BK4605","LU0724618433.USD","PFS","LU2065732104.USD","IE00BZ199S13.USD","IE00BFMHRM44.USD","PR","BBOT","LU0124384867.USD","LU1548497426.USD","LU2357305700.SGD","LU1854104046.USD","LU2360107325.USD","BK4139","BK4097","LU1861214812.USD","LU1861215975.USD","BK4141","LU1720051108.HKD","PRGS","BK4195","BK4211","BK4588","LU1861220033.SGD","LU0266512127.USD","IE00BD6J9T35.USD","ON","LU1978683503.SGD","BK4512","ORR","BK4585","LU0348723411.USD","LU1861219969.SGD","BK4213","LU1854103824.USD","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240536","title":"Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240536","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240536?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"400mg QD 5:2 selected as azenosertib monotherapy pivotal study dose based on favorable benefit-risk profile in DENALI Part 2a, supporting advancement in registration-intended trialsDENALI Phase 2 tria","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293397/0/en/Zentalis-Pharmaceuticals-Reports-First-Quarter-2026-Financial-Results-and-Clinical-Progress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4195","BK4211","PRGS","BK4007","LU2065732104.USD","ADC","PROC","BK4080","PFS","BK4231","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635241459","title":"George Lista, Pres/CEO Prov Protection Plus, sells 2,556 Provident Financial shares for $57,254.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2635241459","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635241459?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:01","pubTimestamp":1778608913,"startTime":"0","endTime":"0","summary":"Provident Financial Services officer George Lista, Pres/CEO Prov Protection Plus, sold 2,556 common shares on May 8 at USD 22.4.Directly held stake fell to 109,262 shares following transaction.Indirect holdings included 10,586 shares via 50% ownership in an LLC, 2,594 shares in a 401, 2,050 shares in an IRA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Provident Financial Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL60Ql2y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"George Lista, Pres/CEO Prov Protection Plus, sells 2,556 Provident Financial shares for $57,254.4","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4211","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634451218","title":"Press Release: Immatics Announces First Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634451218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634451218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"-- SUPRAME Phase 3 interim and final analysis for PRAME cell therapy,anzu-cel, expected to be triggered in 2026, advancing toward the. -- Multiple key clinical data sets expected in 2026 across the portfolio,including four clinical-stage cell therapy and bispecific candidates. targeting cutaneous and uveal melanoma, gynecologic cancers (ovarian and. uterine), head and neck cancer, and other solid tumor indications. -- Phase 1 data readout with second-generation PRAME cell therapy,IMA203CD8, to be presented at the 2026 ASCO meeting, focusing on. -- Phase 1b clinical data from PRAME bispecific, IMA402, as monotherapy and. initial data in combination with an immune checkpoint inhibitor at RP2D. bispecifics, IMA402 targeting PRAME and IMA401 targeting MAGEA4/8 in. -- Cash and cash equivalents as well as other financial assets of $521.5. million1  as of March 31, 2026; cash reach projected. Anzu-cel , previously called IMA203, is Immatics' lead PRAME cell therapy and is expected to be the C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4211","ORR","BK4139","BK4195","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634259712","title":"Turaco Gold Identifies Gold Mineralization at Ivory Coast Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2634259712","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634259712?lang=en_us&edition=fundamental","pubTime":"2026-05-12 08:12","pubTimestamp":1778544770,"startTime":"0","endTime":"0","summary":"Turaco Gold  identified further mineralization from ongoing drilling at the Afema gold project in south-east Ivory Coast, according to a Tuesday Australian bourse filing.The results were up to 28 meters at 2.17 grams per tonne gold (g/t) from 91 meters, including 15 meters at 3.32 g/t gold from 104 meters.The company said the results are from resource extension and infill drilling on the Adiopan-Asupiri deposit, which hosts a current 1.32 million ounce mineral resource estimate  within the 4.65 million ounce Afema MRE.Shallow drilling at the Sikasso prospect returned 21 meters at 2.29 g/t gold from 66 meters, with mineralization at both Bergerie and Sikasso occurring from surface and remaining open with further drilling underway, the filing added.The Afema pre-feasibility study  is due in June, with five drill rigs currently operating with a focus on new discoveries, the company added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TCG.AU","GOAU","IAUM","GOLY","IAUI","GLDM","BK4195","BK4504","PICK","PHYS","CEF","DULL","XME","IAU","DUST","AAAU","BK4207","DBC","UYM","JDST","BK4585","JNUG","SHNY","GLL","GDXU","BK4211","GDXY","GBUG","FGDL","MRE.AU","DZZ","USG","1OZmain","SGDM","DGP","SGOL","BTGD","BK7104","GDXD","GDXJ","BAR","BK7506","GLTR","RING","BK4535","BEGS","GDX","PFS","UGL","OUNZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281115","title":"TMC and Allseas Sign Commercial Agreement for the First Offshore Nodule Recovery Operation","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281115","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281115?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:42","pubTimestamp":1778503320,"startTime":"0","endTime":"0","summary":"The first commercial nodule collection system will have a nameplate production capacity of 3.0MTPA with the surface vessel Hidden Gem  receiving nodules collected by two collector vehicles at a depth of 4km.Allseas has completed concept and basic engineering of critical long-lead systems like the Launch and Recovery Systems, umbilical  and the riser used to transport nodules to the surface.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291911/0/en/TMC-and-Allseas-Sign-Commercial-Agreement-for-the-First-Offshore-Nodule-Recovery-Operation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIA","TMC","LCA","BK4195","BK4168","BK4563","PFS","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634404286","title":"Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404286","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634404286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500800,"startTime":"0","endTime":"0","summary":"Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF (+27%) and APONVIE (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Healthca","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291812/0/en/Heron-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Reaffirms-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CINV","BK4195","BK4563","BK4211","MEC","RA","HRTX","PFS","BK4161","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634469531","title":"Provident Financial Q1 FY26 net income rises 24.1% to $79.4 million; net interest margin widens 6 bps to 3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634469531","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634469531?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:34","pubTimestamp":1778265289,"startTime":"0","endTime":"0","summary":"Provident Financial Services posted net income of $79.4 million, or $0.61 per share, for quarter ended March 31, 2026, up from $64 million, or $0.49 per share, a year earlier.Net interest income rose $12 million to $193.7 million, lifting net interest margin 6 basis points to 3.40%.Provision for credit losses swung to a $2.1 million recapture, including a $4.7 million recapture on loans, versus a $635,000 provision a year earlier.Non-performing loans climbed to $142.9 million, or 0.73% of total loans, driven by four commercial senior housing loans totaling $82.1 million tied to bankruptcy filings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Provident Financial Services Inc. published the original content used to generate this news b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL5RGnqk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Provident Financial Q1 FY26 net income rises 24.1% to $79.4 million; net interest margin widens 6 bps to 3.4%","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4211","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633171836","title":"Press Release: Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633171836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633171836?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:15","pubTimestamp":1778184900,"startTime":"0","endTime":"0","summary":"-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 --. -- Systemic lung cancer programs advancing with additional updates expected throughout 2026 --. WESTLAKE VILLAGE, Calif., May 07, 2026  -- Genelux Corporation , a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2026 and provided general business updates.\"In parallel, we are making steady progress in advancing our manufacturing and operational capabilities to support the continued development of Olvi-Vec and position the Company for potential commercial readiness. Our focus remains on establishing the necessary supply, quality, and organizational infrastructure as our registration-directed programs advance,\" concluded Mr. Zindrick.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4588","GNLX","BK4555","BK4099","TM","BK4195","BK4585","PFS","BK4211","BK4139","PLTM","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633314949","title":"Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633314949","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633314949?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153400,"startTime":"0","endTime":"0","summary":"Oral presentation of silevertinib Phase 2 data in frontline EGFRm NSCLC patients, including preliminary DOR and PFS data, to take place at the 2026 ASCO Annual MeetingFirst patient dosed in the Phase ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289874/0/en/Black-Diamond-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139","PFS","BK4195","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}